Recent Updates
Recently added Catalysts
RCEL Negative Sentiment Score: 20/100

AVITA Medical, Inc. (RCEL) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Key Takeaway: AVITA Medical, Inc. is under investigation for potential federal securities law violations after revealing a backlog of unpaid claims that impacted the demand for its wound care product, Recell. Following the release of its second-quarter financial results on August 7, 2025, the company's stock price fell by 21%. The backlog was attributed to delays in pricing adjudication by CMS contractors, causing uncertainty among providers regarding claims payments. Investors who suffered losses are encouraged to contact legal representatives to discuss potential claims.

Market Sentiment Analysis

CONCERNS & RISKS

  • AVITA Medical faced a significant backlog of unpaid provider claims.
  • The company's stock price dropped 21% after the announcement of reduced RECELL utilization.
  • Uncertainties regarding payment expectations led to reduced provider confidence.

Full Press Release Details

BENSALEM, Pa., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith continues its investigation on behalf of AVITA Medical, Inc. (“Avita” or the “Company”) (NASDAQ: RCEL) investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN AVITA MEDICAL, INC. (RCEL), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.
Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at howardsmith@howardsmithlaw.com, by telephone at (215) 638-4847 or visit our website at www.howardsmithlaw.com.
On August 7, 2025, Avita released its second quarter 2025 financial results, revealing “a six-month backlog in unpaid provider claims for Recell procedures impacted first-half demand.”
The Company explained that contractors assigned by the Centers for Medicare & Medicaid Services to determine pricing of the Company’s wound care product, Recell, “neither assigned a price or assigned an inadequate price and failed to adjudicate claims in a timely manner.”
As a result, “claims accumulated from January through June, creating a significant backlog of unpaid claims and inadequately paid claims to providers for RECELL procedures. This lack of resolution created uncertainty among providers regarding payment expectations and timelines, which led to a reduction in RECELL utilization during the first half of the year.”
On this news, Avita’s stock price fell $1.13, or 21%, to close at $4.25 per share on August 8, 2025, thereby injuring investors.
Contact Us To Participate or Learn More:
If you purchased Avita securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:
Law Offices of Howard G. Smith,
3070 Bristol Pike, Suite 112,
Bensalem, Pennsylvania 19020,
Telephone: (215) 638-4847
Visit our website at: www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Law Offices of Howard G. Smith
Howard G. Smith, Esquire

Tags

Frequently Asked Questions

What is the investigation about Avita Medical?

The Law Offices of Howard G. Smith are investigating Avita Medical for potential federal securities law violations.

Why did Avita's stock price drop recently?

Avita's stock fell 21% after revealing a backlog in unpaid provider claims affecting demand.

What caused the backlog in Avita's claims?

A lack of timely adjudication and pricing by Medicare contractors resulted in a claims backlog.

How can investors contact Howard G. Smith?

Investors can reach Howard G. Smith via email at howardsmith@howardsmithlaw.com or by phone.

Where is the Law Offices of Howard G. Smith located?

The offices are located at 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania.

Last updated: Sep 3, 2025